The Scottish Medicines Consortium has approved the use of Gilead’s Truvada for use in preventing new HIV infections, so called pre-exposure prophylaxis (PrEP).
A diabetes awareness campaign from CDM London proved to be the “Best of Show” at this year’s PM Society Awards, recognising the crème de la crème in pharma marketing.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.